Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Peptidylprolyl isomerase A pseudogene 21 (PPIAP21), also known as dJ269M15.1, is a pseudogene related to the peptidylprolyl isomerase A (PPIA) gene. It is not considered a therapeutic target as it is a pseudogene, not a functional protein, enzyme, receptor, transporter, or traditional drug target. The gene exists as described, with no evidence of error in the name or concept. It has no proven functional protein product, as pseudogenes are generally nonfunctional with respect to protein coding. There is no direct implication of PPIAP21 in diseases, though its parent gene, PPIA, is involved in various diseases.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Peptidylprolyl isomerase A pseudogene 21 (PPIAP21).